Effect of early initiation of statins on survival in patients with acute myocardial infarction (the USIC 2000 Registry) - 21/08/11
Doi : 10.1016/j.amjcard.2004.10.016
Jean Ferrières, MD a, ⁎ 
, Jean-Pierre Cambou, MD a, Pascal Guéret, MD b, Youcef Boutalbi, MD c, Jean-Marc Lablanche, MD d, Guy Hanania, MD e, Nathalie Genès, MD c, Christelle Cantet, MSc a, Nicolas Danchin, MD f
, Jean-Pierre Cambou, MD a, Pascal Guéret, MD b, Youcef Boutalbi, MD c, Jean-Marc Lablanche, MD d, Guy Hanania, MD e, Nathalie Genès, MD c, Christelle Cantet, MSc a, Nicolas Danchin, MD f a Department of Epidemiology, INSERM U558, Toulouse, France
b Department of Cardiology, Henri Mondor Hospital, Créteil, France
c Laboratoire Aventis, Paris, France
d Department of Cardiology B, Cardiological Hospital, Lille, France
e Department of Cardiology, Robert-Ballanger Hospital, Aulnay-sous-Bois, France
f Service de Cardiologie, HEGP, Paris, France
*Dr. Ferrières's address is: Department of Epidemiology, INSERM U558, Faculté de Médecine, 37 allées Jules Guesde 31073 Toulouse cedex, France
Résumé |
We evaluated the association of statin initiation within 48 hours of admission for an acute myocardial infarction with a 1-year prognosis on a nationwide scale. Patients who received a statin within 48 hours of admission but not before hospitalization had an improved prognosis (hazard ratio 0.57, 95% confidence interval 0.38 to 0.86, p <0.007) after adjustment for covariates and propensity score.
Le texte complet de cet article est disponible en PDF.| The study was supported by funding from Aventis Pharmaceuticals, Paris, France. |
© 2005
Excerpta Medica Inc. Tous droits réservés.
Vol 95 - N° 4
P. 486-489 - février 2005 Retour au numéro
Article précédent
- Lipid management in patients with unstable angina pectoris and non–ST-segment elevation acute myocardial infarction (from CRUSADE)
- JoAnne M. Foody, Matthew T. Roe, Anita Y. Chen, Sidney C. Smith, Ralph G. Brindis, Eric D. Peterson, W. Brian Gibler, E. Magnus Ohman, CRUSADE Investigators
- Effect of statin therapy on risk of ventricular arrhythmia among patients with coronary artery disease and an implantable cardioverter-defibrillator
- John H. Chiu, Raed H. Abdelhadi, Mina K. Chung, Hitinder S. Gurm, Nassir F. Marrouche, Walid I. Saliba, Andrea Natale, David O. Martin
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?